The pronociceptive role of 5-HT6 receptors in ventrolateral orbital cortex in a rat formalin test model. (December 2019)

• Record Type: Journal Article
• Authors: Zhang, Yu-Xiang; Yang, Mei; Liang, Feng; Li, Shao-Qing; Yang, Jing-Si; Huo, Fu-Quan; Yan, Chun-Xia
• Is Part Of: Neurochemistry international. Volume 131(2019)
• Publication Date: 2019-12
• Subjects: Antinociception -- Pronociception -- Formalin test -- 5-HT6 receptor -- Ventrolateral orbital cortex; AI agranular insular cortex -- Cl claustrum -- fmi forceps minor corpos callosum -- VLO ventrolateral orbital cortex -- DMSO dimethyl sulfoxide -- i.p. intraperitoneally -- KYNA kynurenic acid -- vlPAG ventrolateral periaqueductal gray -- AC adenylate cyclase -- PKA protein kinase A -- Sm thalamic nucleus submedius; Neurochemistry -- Periodicals; Neurochemistry -- Periodicals; Neurochimie -- Périodiques; Neurochemistry; Periodicals; 612.804205
• DOI: 10.1016/j.neuint.2019.104562
• Languages: English
• ISSNs: 0197-0186

Abstract

Abstract: Recent studies have shown the 5-HT6 receptors are expressed in regions which are important in pain processing such as the cortex, amygdala, thalamus, PAG, spinal cord and dorsal root ganglia (DRG), suggesting a putative role of 5-HT6 receptors in pain modulation. The ventrolateral orbital cortex (VLO) is part of an endogenous analgesic system, consisting of the spinal cord – thalamic nucleus submedius (Sm) – VLO – periaqueductal gray (PAG) – spinal cord loop. The present study assessed the possible role of 5-HT6 receptors in the VLO in formalin-induced inflammatory pain model. Firstly we found that microinjection of selective 5-HT6 receptor agonists EMD-386088 (5 μg in 0.5 μl) and WAY-208466 (8 μg in 0.5 μl) both augmented 5% formalin-induced nociceptive behavior. Microinjection of selective 5-HT6 receptor antagonist SB-258585 (1, 2 and 4 μg in 0.5 μl) significantly reduced formalin-induced flinching. Besides, the pronociceptive effects of EMD-386088 and WAY-208466 were dramatically reduced by SB-258585, implicating 5-HT6 receptor mechanisms in mediating these responses. In addition, the pronociceptive effect of EMD-386088 was also prevented by the adenylate cyclase (AC) inhibitor SQ-22536 (2 nmol in 0.5 μl) and the protein kinase A (PKA) inhibitor H89 (10 nmol in 0.5 μl), respectively. We further confirmed the above results with quantification of spinal c-fos expression. Taken together, our results suggested that 5-HT6 receptors play a pronociceptive role in the VLO in the rat formalin test due to its activation of AC - PKA pathway. Therefore, cerebral cortical 5-HT6 receptors could be a new target to develop analgesic drugs. Highlights: Intro-VLO of 5-HT6 receptor agonists enhanced nociceptive behavior and spinal Fos expression. Intro-VLO of 5-HT6 receptor antagonist depressed nociceptive behavior and spinal Fos expression. The pronociceptive effect of 5-HT6 receptor agonists was blocked by 5-HT6 receptor antagonist. The pronociceptive effect of 5-HT6 receptor agonist was blocked by AC inhibitor. The pronociceptive effect of 5-HT6 receptor agonist was blocked by PKA inhibitor.